PHARMACEUTICAL COMPOSITIONS COMPRISING SEPIAPTERIN AND USES THEREOF
申请人:Censa Pharmaceuticals Inc.
公开号:US20200061070A1
公开(公告)日:2020-02-27
The present invention features pharmaceutical compositions including sepiapterin, or a pharmaceutically acceptable salt and/or co-crystal thereof, and methods for the treatment of tetrahydrobiopterin-related disorders (e.g., tetrahydrobiopterin deficiency or phenylketonuria) with such compositions.
US9181254B2
申请人:——
公开号:US9181254B2
公开(公告)日:2015-11-10
[EN] PHARMACEUTICAL COMPOSITIONS COMPRISING SEPIAPTERIN AND USES THEREOF<br/>[FR] COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA SÉPIAPTÉRINE ET SES UTILISATIONS
申请人:CENSA PHARMACEUTICALS INC
公开号:WO2019046849A1
公开(公告)日:2019-03-07
The present invention features pharmaceutical compositions including sepiapterin, or a pharmaceutically acceptable salt and/or co-crystal thereof, and methods for the treatment of tetrahydrobiopterin-related disorders (e.g., tetrahydrobiopterin deficiency or phenylketonuria) with such compositions.
METHOD FOR PRODUCING SEPIAPTERIN AND TETRAHYDROLACTOYLPTERIN